{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:51Z","timestamp":1787021271981,"version":"build-2736575974"},"reference-count":74,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK121888"],"award-info":[{"award-number":["K23DK121888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DK132121"],"award-info":[{"award-number":["R03DK132121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Labcorp"},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["E.033"],"award-info":[{"award-number":["E.033"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"University Medical Center Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Netherlands Heart Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Patients with adrenal hormone excess demonstrate increased cardiovascular (CV) risk and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to determine the effect of adrenal disorders on the inflammation marker glycoprotein acetylation (GlycA), total branched-chain amino acids (BCAAs), ketone bodies, and the gut microbiome-derived metabolites trimethylamine N-oxide (TMAO) and betaine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a single-center cross-sectional study of patients with nonfunctioning adenomas (NFAs), mild autonomous cortisol secretion (MACS), primary aldosteronism (PA), Cushing syndrome (CS), pheochromocytoma\/paragangliomas (PPGLs), other benign or malignant adrenal masses, and adrenocortical carcinoma (ACC) between January 2015 and July 2022 (n = 802). Referent individuals included participants in the PREVEND (Prevention of Renal and Vascular End-Stage Disease) study (n = 5241). GlycA, BCAAs, ketone bodies, TMAO, and betaine were measured using nuclear magnetic resonance spectroscopy. Multivariable logistic analyses were adjusted for age, sex, body mass index, smoking, hypertension, diabetes mellitus, and statin therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In age- and sex-adjusted comparison to referent individuals, increased GlycA was noted in all patient categories, increased BCAAs in NFA, MACS, CS, PA, and ACC, increased TMAO in patients with other malignant adrenal masses, increased betaine in NFA and MACS, and increased ketone bodies in NFA, CS, and ACC. Essentially similar findings were observed in fully adjusted analysis and after exclusion of participants with diabetes and CV disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with functioning and nonfunctioning adrenal masses demonstrated increased GlycA and BCAAs, biomarkers associated with adverse cardiometabolic disorders and mortality. Patients with NFA demonstrated an adverse metabolic profile similar to patients with MACS and CS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae204","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T18:49:58Z","timestamp":1711478998000},"page":"e330-e338","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced Chronic Inflammation and Increased Branched-Chain Amino Acids in Adrenal Disorders: A Cross-Sectional Study"],"prefix":"10.1210","volume":"110","author":[{"given":"Annop A","family":"Kittithaworn","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Dogra","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]},{"name":"Division of Endocrinology, Diabetes and Metabolism, University of Wisconsin\u2013Madison School of Medicine and Public Health , Madison, WI 53726 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-6229","authenticated-orcid":false,"given":"Jasmine","family":"Saini","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eke G","family":"Gruppen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Medical Center Groningen and University of Groningen , Groningen 9700 RB ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Achenbach","sequence":"additional","affiliation":[{"name":"Division of Clinical Trials and Biostatistics, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8794-0318","authenticated-orcid":false,"given":"Kai","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Thangamuthu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery A","family":"Connelly","sequence":"additional","affiliation":[{"name":"Labcorp , Morrisville, NC 27560 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3844-5254","authenticated-orcid":false,"given":"Robin P F","family":"Dullaart","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Medical Center Groningen and University of Groningen , Groningen 9700 RB ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-2524","authenticated-orcid":false,"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic , Rochester, MN 55905 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"issue":"7","key":"2025012110280093800_dgae204-B1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2025012110280093800_dgae204-B2","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1210\/clinem\/dgab468","article-title":"Cardiometabolic outcomes and mortality in patients with adrenal adenomas in a population-based setting","volume":"106","author":"Zhang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025012110280093800_dgae204-B3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/gs.2019.11.03","article-title":"Cardiovascular risk and mortality in patients with active and treated hypercortisolism","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"1","key":"2025012110280093800_dgae204-B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025012110280093800_dgae204-B5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?","volume":"98","author":"Stolk","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"2025012110280093800_dgae204-B6","doi-asserted-by":"crossref","first-page":"e15985","DOI":"10.1097\/MD.0000000000015985","article-title":"Cardiovascular risk in primary aldosteronism: a systematic review and meta-analysis","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2025012110280093800_dgae204-B7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ejendo\/lvad113","article-title":"High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess\u2014a cross-sectional multi-centre study with prospective enrolment","volume":"189","author":"Dogra","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2025012110280093800_dgae204-B8","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025012110280093800_dgae204-B9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"8","key":"2025012110280093800_dgae204-B10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"Nonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"2025012110280093800_dgae204-B11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"5","key":"2025012110280093800_dgae204-B12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/EJE-21-0458","article-title":"Abnormal body composition in patients with adrenal adenomas","volume":"185","author":"Delivanis","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2025012110280093800_dgae204-B13","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1210\/clinem\/dgad074","article-title":"Mortality not increased in patients with nonfunctional adrenal adenomas: a matched cohort study","volume":"108","author":"Kjellbom","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025012110280093800_dgae204-B14","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"THERAPY OF ENDOCRINE DISEASE: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025012110280093800_dgae204-B15","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2025012110280093800_dgae204-B16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of Endocrine Surgeons guidelines for adrenalectomy: executive summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"issue":"1","key":"2025012110280093800_dgae204-B17","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European society of endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European network for the study of adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025012110280093800_dgae204-B18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12967-017-1321-6","article-title":"Glyca, a novel biomarker of systemic inflammation and cardiovascular disease risk","volume":"15","author":"Connelly","year":"2017","journal-title":"J Transl Med"},{"issue":"3","key":"2025012110280093800_dgae204-B19","first-page":"152","article-title":"Increased glycoprotein acetylation is associated with high cardiac event rates: analysis using coronary computed tomography angiography","volume":"20","author":"An","year":"2018","journal-title":"Anatol J Cardiol"},{"key":"2025012110280093800_dgae204-B20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2015.11.001","article-title":"Glyca, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study","volume":"452","author":"Connelly","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2025012110280093800_dgae204-B21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/joim.12953","article-title":"Glyca, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis","volume":"286","author":"Gruppen","year":"2019","journal-title":"J Intern Med"},{"issue":"8","key":"2025012110280093800_dgae204-B22","doi-asserted-by":"crossref","first-page":"e007067","DOI":"10.1161\/CIRCHEARTFAILURE.120.007067","article-title":"Association of the novel inflammatory marker GlycA and incident heart failure and its subtypes of preserved and reduced ejection fraction: the multi-ethnic study of atherosclerosis","volume":"13","author":"Jang","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"2","key":"2025012110280093800_dgae204-B23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12020-023-03319-5","article-title":"Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62)","volume":"80","author":"Bourgonje","year":"2023","journal-title":"Endocrine"},{"issue":"6","key":"2025012110280093800_dgae204-B24","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/HYPERTENSIONAHA.119.13735","article-title":"Concentration of branched-chain amino acids is a strong risk marker for incident hypertension","volume":"74","author":"Flores-Guerrero","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"2025012110280093800_dgae204-B25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1373\/clinchem.2015.251710","article-title":"Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED trial","volume":"62","author":"Ruiz-Canela","year":"2016","journal-title":"Clin Chem"},{"key":"2025012110280093800_dgae204-B26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clinbiochem.2018.02.001","article-title":"A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness","volume":"54","author":"Wolak-Dinsmore","year":"2018","journal-title":"Clin Biochem"},{"issue":"3","key":"2025012110280093800_dgae204-B27","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/dc12-0895","article-title":"Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults","volume":"36","author":"Wurtz","year":"2013","journal-title":"Diabetes Care"},{"issue":"7","key":"2025012110280093800_dgae204-B28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.metabol.2013.01.007","article-title":"Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness","volume":"62","author":"Batch","year":"2013","journal-title":"Metabolism"},{"issue":"1","key":"2025012110280093800_dgae204-B29","doi-asserted-by":"crossref","first-page":"15580","DOI":"10.1038\/s41598-019-52082-z","article-title":"Trimethylamine-N-Oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease","volume":"9","author":"Roncal","year":"2019","journal-title":"Sci Rep"},{"issue":"17","key":"2025012110280093800_dgae204-B30","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"issue":"11","key":"2025012110280093800_dgae204-B31","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/jcm8111813","article-title":"High betaine, a trimethylamine N-oxide related metabolite, is prospectively associated with low future risk of type 2 diabetes mellitus in the PREVEND study","volume":"8","author":"Garcia","year":"2019","journal-title":"J Clin Med"},{"issue":"2","key":"2025012110280093800_dgae204-B32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/jcm9020321","article-title":"Ketone bodies are mildly elevated in subjects with type 2 diabetes mellitus and are inversely associated with insulin resistance as measured by the lipoprotein insulin resistance index","volume":"9","author":"Garcia","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"2025012110280093800_dgae204-B33","doi-asserted-by":"crossref","first-page":"e13627","DOI":"10.1111\/eci.13627","article-title":"Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort","volume":"51","author":"Post","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2025012110280093800_dgae204-B34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cardfail.2022.09.009","article-title":"Longitudinal changes in circulating ketone body levels in patients with acute heart failure: a post hoc analysis of the EMPA-response-AHF trial","volume":"29","author":"Voorrips","year":"2023","journal-title":"J Card Fail"},{"issue":"9","key":"2025012110280093800_dgae204-B35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/db22-0826","article-title":"Fasting ketone bodies and incident type 2 diabetes in the general population","volume":"72","author":"Szili-Torok","year":"2023","journal-title":"Diabetes"},{"key":"2025012110280093800_dgae204-B36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cca.2016.06.012","article-title":"Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer","volume":"459","author":"Connelly","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"9","key":"2025012110280093800_dgae204-B37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/aje\/kwx016","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on\u2014omic technologies","volume":"186","author":"Wurtz","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2025012110280093800_dgae204-B38","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025012110280093800_dgae204-B39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2025012110280093800_dgae204-B40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3945\/ajcn.116.133744","article-title":"Glyca, a novel proinflammatory glycoprotein biomarker, and high-sensitivity C-reactive protein are inversely associated with sodium intake after controlling for adiposity: the prevention of renal and vascular end-stage disease study","volume":"104","author":"Gruppen","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"2025012110280093800_dgae204-B41","doi-asserted-by":"crossref","first-page":"e0139057","DOI":"10.1371\/journal.pone.0139057","article-title":"Glyca, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with C-reactive protein and renal function","volume":"10","author":"Gruppen","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"2025012110280093800_dgae204-B42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2012.06.017","article-title":"Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (prevention of renal and vascular endstage disease) study","volume":"60","author":"Smink","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2025012110280093800_dgae204-B43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2796.2010.02323.x","article-title":"Apolipoprotein B\/A-I and total cholesterol\/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein","volume":"269","author":"Kappelle","year":"2011","journal-title":"J Intern Med Feb"},{"issue":"1","key":"2025012110280093800_dgae204-B44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"issue":"16-17","key":"2025012110280093800_dgae204-B45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.clinbiochem.2017.06.003","article-title":"NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting","volume":"50","author":"Garcia","year":"2017","journal-title":"Clin Biochem"},{"issue":"5","key":"2025012110280093800_dgae204-B46","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"Glyca: a composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"key":"2025012110280093800_dgae204-B47","unstructured":"Bancos I . 2023. Supplemental data: metabolic profiling in adrenal disorders. Figshare. doi:10.6084\/m9.figshare.24784074.v1."},{"key":"2025012110280093800_dgae204-B48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2018.10.029","article-title":"Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: the PREVEND study","volume":"488","author":"Gruppen","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"1","key":"2025012110280093800_dgae204-B49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/clinchem\/hvac160","article-title":"The inflammation biomarker GlycA reflects plasma N-glycan branching","volume":"69","author":"Noel","year":"2023","journal-title":"Clin Chem"},{"issue":"3","key":"2025012110280093800_dgae204-B50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.arcmed.2018.07.002","article-title":"Serum amyloid A, paraoxonase-1 activity, and apolipoprotein concentrations as biomarkers of subclinical atherosclerosis risk in adrenal incidentaloma patients","volume":"49","author":"Imga","year":"2018","journal-title":"Arch Med Res"},{"issue":"8","key":"2025012110280093800_dgae204-B51","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","article-title":"Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis","volume":"37","author":"Tuna","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2025012110280093800_dgae204-B52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ejendo\/lvad041","article-title":"Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome","volume":"188","author":"Vogel","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025012110280093800_dgae204-B53","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000336589","article-title":"Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas","volume":"21","author":"Yener","year":"2012","journal-title":"Med Princ Pract"},{"issue":"1","key":"2025012110280093800_dgae204-B54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000107289","article-title":"Elevated inflammation markers in pheochromocytoma compared to other forms of hypertension","volume":"14","author":"Zelinka","year":"2007","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"2025012110280093800_dgae204-B55","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12020-020-02235-2","article-title":"Lipoprotein insulin resistance score and branched-chain amino acids increase after adrenalectomy for unilateral aldosterone-producing adenoma: a preliminary study","volume":"68","author":"Adolf","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"2025012110280093800_dgae204-B56","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cen.13891","article-title":"Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker","volume":"90","author":"Berends","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"2025012110280093800_dgae204-B57","doi-asserted-by":"crossref","first-page":"153070","DOI":"10.1016\/j.prp.2020.153070","article-title":"Inflammation in the neoplasms of the adrenal gland: is there a prognostic role? An immunohistochemical study","volume":"216","author":"Guadagno","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"5","key":"2025012110280093800_dgae204-B58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0026-0495(86)90128-9","article-title":"Acute cortisol excess results in unimpaired insulin action on lipolysis and branched chain amino acids, but not on glucose kinetics and C-peptide concentrations in man","volume":"35","author":"Clerc","year":"1986","journal-title":"Metabolism"},{"issue":"5","key":"2025012110280093800_dgae204-B59","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab"},{"issue":"12","key":"2025012110280093800_dgae204-B60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2025012110280093800_dgae204-B61","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00125-017-4222-6","article-title":"Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels","volume":"60","author":"Mahendran","year":"2017","journal-title":"Diabetologia"},{"issue":"12","key":"2025012110280093800_dgae204-B62","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/jcm7120513","article-title":"Plasma branched-chain amino acids and risk of incident type 2 diabetes: results from the PREVEND prospective cohort study","volume":"7","author":"Flores-Guerrero","year":"2018","journal-title":"J Clin Med"},{"key":"2025012110280093800_dgae204-B63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clinbiochem.2022.01.009","article-title":"Branched chain amino acids are associated with metabolic complications in liver transplant recipients","volume":"102","author":"Bohler","year":"2022","journal-title":"Clin Biochem"},{"issue":"4","key":"2025012110280093800_dgae204-B64","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/met.2016.0145","article-title":"Branched chain amino acids are associated with insulin resistance independent of leptin and adiponectin in subjects with varying degrees of glucose tolerance","volume":"15","author":"Connelly","year":"2017","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"2025012110280093800_dgae204-B65","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"issue":"4","key":"2025012110280093800_dgae204-B66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"2025012110280093800_dgae204-B67","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1124\/dmd.116.070615","article-title":"Trimethylamine and trimethylamine N-oxide, a flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease","volume":"44","author":"Fennema","year":"2016","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"2025012110280093800_dgae204-B68","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bbagen.2016.02.001","article-title":"Betaine chemistry, roles, and potential use in liver disease","volume":"1860","author":"Day","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2025012110280093800_dgae204-B69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/liv.15310","article-title":"High plasma levels of betaine, a trimethylamine N-oxide-related metabolite, are associated with the severity of cirrhosis","volume":"43","author":"van den Berg","year":"2023","journal-title":"Liver Int"},{"key":"2025012110280093800_dgae204-B70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2019.01.043","article-title":"Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt\/mTOR signaling in methionine-choline deficiency-induced fatty liver disease","volume":"848","author":"Veskovic","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"2025012110280093800_dgae204-B71","doi-asserted-by":"crossref","first-page":"108985","DOI":"10.1016\/j.diabres.2021.108985","article-title":"Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids","volume":"178","author":"Lee","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2025012110280093800_dgae204-B72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2019.11.001","article-title":"Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention","volume":"31","author":"Liu","year":"2020","journal-title":"Cell Metab"},{"issue":"Suppl 1","key":"2025012110280093800_dgae204-B73","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ijo.0800789","article-title":"Catecholamine-induced lipolysis in obesity","volume":"23","author":"Arner","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2-03","key":"2025012110280093800_dgae204-B74","first-page":"129","article-title":"Metabolic alterations in patients with pheochromocytoma","volume":"127","author":"Erlic","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae204\/57273413\/dgae204.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/2\/e330\/57273413\/dgae204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/2\/e330\/57273413\/dgae204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:29:19Z","timestamp":1737437359000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/2\/e330\/7636629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3,28]]},"published-print":{"date-parts":[[2025,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae204","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,3,28]]}}}